China Pharma Holdings, Inc.
CPHI Healthcare Drug Manufacturers Specialty & Generic
China Pharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 million, down 8.49% from fiscal 2024. In the quarter to June 2026, revenue fell 7.56%, EPS grew 75.0%, free cash flow fell 113.6% and total debt fell 2.92%, each against the same quarter a year earlier.
Follow CPHI
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(4.47) | (3.55) | (3.19) | (3.19) |
+8 more TTM periods Free account |
Depreciation & Amortization |
3.05 | 2.23 | 1.58 | 1.51 | |
Non Cash Items (Other) |
(13.53) | (13.33) | (13.11) | 0.52 | |
Accounts Receivable Change |
13.23 | 13.36 | 13.21 | (0.52) | |
Change in inventories |
0.79 | 0.68 | 0.59 | 0.89 | |
Accounts Payable Change |
0.70 | 0.79 | 1.12 | 0.96 | |
Change in other assets and liabilities |
0.09 | (0.02) | (0.04) | 0.11 | |
Operating Cash Flow |
(0.14) | 0.17 | 0.15 | 0.30 | |
Capital expenditures |
— | — | (0.06) | (0.08) | |
Change in intangibles (net) |
— | — | (0.13) | (0.38) | |
Investing cash flow |
(0.08) | (0.08) | (0.14) | (0.40) | |
Repayment/Issuance of Debt (Net) |
(0.15) | (0.30) | (0.29) | (0.28) | |
Financing cash flow |
(0.15) | (0.30) | (0.29) | (0.28) | |
Exchange Rate Adjustment |
0.05 | (0.04) | 0.00 | (0.07) | |
Change in Cash |
(0.32) | (0.24) | (0.28) | (0.45) | |
Beginning Cash |
0.35 | 0.35 | 0.63 | 0.63 | |
Ending Cash |
0.03 | 0.10 | 0.35 | 0.18 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
14.81 | 14.81 | 14.87 | 1.45 |